|
C20ORF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.626200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.135600E-01 |
| Normal-vs-Stage2 |
3.011500E-02 |
| Normal-vs-Stage3 |
5.595000E-01 |
| Normal-vs-Stage4 |
2.586600E-01 |
| Stage1-vs-Stage2 |
1.611560E-01 |
| Stage1-vs-Stage3 |
6.024400E-01 |
| Stage1-vs-Stage4 |
4.755600E-02 |
| Stage2-vs-Stage3 |
7.444400E-02 |
| Stage2-vs-Stage4 |
6.841700E-03 |
| Stage3-vs-Stage4 |
1.106220E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.027400E-01 |
| Normal-vs-AfricanAmerican |
7.162400E-01 |
| Normal-vs-Asian |
6.531000E-01 |
| Caucasian-vs-AfricanAmerican |
4.372200E-01 |
| Caucasian-vs-Asian |
3.106600E-01 |
| AfricanAmerican-vs-Asian |
9.803800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.105200E-01 |
| Normal-vs-Female |
2.427000E-01 |
| Male-vs-Female |
8.395400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.047000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.825600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.093810E-01 |
| Normal-vs-Age(81-100Yrs) |
8.842500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.317600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.482600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.927600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.810300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.988570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.438600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.319600E-01 |
| Classical-VS-Follicular |
6.20989999999821E-05 |
| Classical-VS-Other |
3.114400E-01 |
| Classical-VS-Normal |
9.968400E-01 |
| Tall-VS-Follicular |
5.63419999999315E-05 |
| Tall-VS-Other |
4.557400E-01 |
| Tall-VS-Normal |
2.832600E-01 |
| Follicular-VS-Other |
3.276200E-02 |
| Follicular-VS-Normal |
3.237000E-04 |
| Other-VS-Normal |
1.553160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.871700E-02 |
| Normal-vs-N1 |
1.524950E-01 |
| N0-vs-N1 |
1.855220E-03 |
|
|
